MIME-Version: 1.0
Date: Thu, 30 Jul 2020 10:25:49 +0000
References: <AM6PR08MB32404C998C1F623AAD3BEF56F4710@AM6PR08MB3240.eurprd08.prod.outlook.com>
In-Reply-To: <AM6PR08MB32404C998C1F623AAD3BEF56F4710@AM6PR08MB3240.eurprd08.prod.outlook.com>
Message-ID: <CACNgykOyW12xTYMr77mNhCJvYzzR-kHg8O_X7rwFhsbSKjizkQ@mail.gmail.com>
Subject: Re: follow up
From: Josh Klein <josh@josh.is>
To: "Coplan, Linda" <linda.coplan@takeda.com>
Cc: Joshua William Klein <josh@josh.is>
Content-Type: multipart/alternative; boundary="000000000000a9f90d05aba61826"

--000000000000a9f90d05aba61826
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

Ok, thanks for the update - really appreciate it! I'll wait for your word.

Much obliged,
Josh
=E1=90=A7

On Thu, Jul 30, 2020 at 10:21 AM Coplan, Linda <linda.coplan@takeda.com>
wrote:

> Hi Josh
>
> Luis did not mention this at all, we had a packed agenda, he is quite bus=
y
> managing day to day and I really feel we will be ok here if you come in t=
o
> support the long term approach.  But let me double back with Padma to see
> if Luis is suppose to reach out to you or you to Luis and then I am
> checking on the CIO.
>
>
>
> More to come.
>
>
>
> Take Care
>
> Linda
>
>
>
> *Linda Coplan*
>
> *Head of HR*
>
> *Plasma-Derived Therapies Business Unit*
>
>
>
> *Takeda Pharmaceuticals, USA, Inc*
>
> 1200 Lakeside Drive
>
> Bannockburn, IL 60015
>
> Mobile:  847-334-5296
>
>
>
> linda.coplan@takeda.com
>
>
>
>
>
>
>
>
> The content of this email and of any files transmitted may contain
> confidential, proprietary or legally privileged information and is intend=
ed
> solely for the use of the person/s or entity/ies to whom it is addressed.
> If you have received this email in error you have no permission whatsoeve=
r
> to use, copy, disclose or forward all or any of its contents. Please
> immediately notify the sender and thereafter delete this email and any
> attachments.
>

--000000000000a9f90d05aba61826
Content-Type: text/html; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

<div dir=3D"ltr">Ok, thanks for the update - really appreciate it! I&#39;ll=
 wait for your word.<br><div><br></div><div>Much obliged,<br>Josh</div></di=
v><div hspace=3D"streak-pt-mark" style=3D"max-height:1px"><img alt=3D"" sty=
le=3D"width:0px;max-height:0px;overflow:hidden" src=3D"https://mailfoogae.a=
ppspot.com/t?sender=3Daam9zaEBqb3NoLmlz&amp;type=3Dzerocontent&amp;guid=3D7=
0464920-7ab0-4cc6-9b50-b2589c55b496"><font color=3D"#ffffff" size=3D"1">=E1=
=90=A7</font></div><br><div class=3D"gmail_quote"><div dir=3D"ltr" class=3D=
"gmail_attr">On Thu, Jul 30, 2020 at 10:21 AM Coplan, Linda &lt;<a href=3D"=
mailto:linda.coplan@takeda.com">linda.coplan@takeda.com</a>&gt; wrote:<br><=
/div><blockquote class=3D"gmail_quote" style=3D"margin:0px 0px 0px 0.8ex;bo=
rder-left:1px solid rgb(204,204,204);padding-left:1ex">





<div lang=3D"EN-US">
<div class=3D"gmail-m_3359476615060249207WordSection1">
<p class=3D"MsoNormal">Hi Josh<u></u><u></u></p>
<p class=3D"MsoNormal">Luis did not mention this at all, we had a packed ag=
enda, he is quite busy managing day to day and I really feel we will be ok =
here if you come in to support the long term approach.=C2=A0 But let me dou=
ble back with Padma to see if Luis is suppose
 to reach out to you or you to Luis and then I am checking on the CIO.<u></=
u><u></u></p>
<p class=3D"MsoNormal"><u></u>=C2=A0<u></u></p>
<p class=3D"MsoNormal">More to come.<u></u><u></u></p>
<p class=3D"MsoNormal"><u></u>=C2=A0<u></u></p>
<p class=3D"MsoNormal">Take Care<u></u><u></u></p>
<p class=3D"MsoNormal">Linda<u></u><u></u></p>
<p class=3D"MsoNormal"><u></u>=C2=A0<u></u></p>
<p class=3D"MsoNormal"><b><span style=3D"font-size:10.5pt">Linda Coplan<u><=
/u><u></u></span></b></p>
<p class=3D"MsoNormal"><b><span style=3D"font-size:10.5pt">Head of HR<u></u=
><u></u></span></b></p>
<p class=3D"MsoNormal"><b><span style=3D"font-size:10.5pt;color:black">Plas=
ma-Derived Therapies Business Unit<u></u><u></u></span></b></p>
<p class=3D"MsoNormal"><b><u></u>=C2=A0<u></u></b></p>
<p class=3D"MsoNormal"><b><span style=3D"font-size:9pt;font-family:Arial,sa=
ns-serif;color:gray">Takeda Pharmaceuticals, USA, Inc<u></u><u></u></span><=
/b></p>
<p class=3D"MsoNormal"><span style=3D"font-size:9pt;font-family:Arial,sans-=
serif;color:gray">1200 Lakeside Drive<u></u><u></u></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:9pt;font-family:Arial,sans-=
serif;color:gray">Bannockburn, IL 60015<u></u><u></u></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:9pt;font-family:Arial,sans-=
serif;color:gray">Mobile:=C2=A0 847-334-5296<u></u><u></u></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:9pt;font-family:Arial,sans-=
serif;color:gray"><u></u>=C2=A0<u></u></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:9pt;font-family:Arial,sans-=
serif;color:gray"><a href=3D"mailto:linda.coplan@takeda.com" target=3D"_bla=
nk"><span style=3D"color:blue">linda.coplan@takeda.com</span></a><u></u><u>=
</u></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:9pt;font-family:Arial,sans-=
serif;color:gray"><u></u>=C2=A0<u></u></span></p>
<p class=3D"MsoNormal"><u></u>=C2=A0<u></u></p>
<p class=3D"MsoNormal"><b><u></u>=C2=A0<u></u></b></p>
<p class=3D"MsoNormal"><u></u>=C2=A0<u></u></p>
</div>

<div>
The content of this email and of any files transmitted may contain confiden=
tial, proprietary or legally privileged information and is intended solely =
for the use of the person/s or entity/ies to whom it is addressed. If you h=
ave received this email in error you have no permission whatsoever to use, =
copy, disclose or forward all or any of its contents. Please immediately no=
tify the sender and thereafter delete this email and any attachments.<br>
</div></div>

</blockquote></div>

--000000000000a9f90d05aba61826--